References

Key articles

Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet. 2011 Mar 5;377(9768):849-62.Full text  Abstract

Kortepeter MG, Bausch DG, Bray M. Basic clinical and laboratory features of filoviral hemorrhagic fever. J Infect Dis. 2011 Nov;204 Suppl 3:S810-6.Full text  Abstract

WHO Ebola Response Team. Ebola virus disease in West Africa: the first 9 months of the epidemic and forward projections. N Engl J Med. 2014 Oct 16;371(16):1481-95.Full text  Abstract

Hunt L, Gupta-Wright A, Simms V, et al. Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study. Lancet Infect Dis. 2015 Nov;15(11):1292-9. Abstract

Fowler RA, Fletcher T, Fischer WA 2nd, et al. Caring for critically ill patients with Ebola virus disease. Perspectives from West Africa. Am J Respir Crit Care Med. 2014 Oct 1;190(7):733-7.Full text  Abstract

Lado M, Walker N, Baker P, et al. Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study. Lancet Infect Dis. 2015 Sep;15(9):1024-33. Abstract

World Health Organization. Manual for the care and management of patients in Ebola care units/community care centres: interim emergency guidance. January 2015 [internet publication].Full text

World Health Organization. Clinical management of patients with viral haemorrhagic fever: a pocket guide for the front-line health worker. February 2016 [internet publication].Full text

World Health Organization. Interim guidance: potential Ebola therapies and vaccines. November 2014 [internet publication].Full text

World Health Organization. Therapeutics for Ebola virus disease - Democratic Republic of the Congo. Aug 2022 [internet publication].Full text

Reference articles

1. Centers for Disease Control and Prevention. About Ebola virus disease. Nov 2019 [internet publication].Full text

2. World Health Organization. Ebola virus disease fact sheet. Feb 2020 [internet publication].Full text

3. Kuhn JH, Andersen, KG, Baize, S, et al. Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014. Viruses. 2014 Nov 24;6(11):4760-99.Full text  Abstract

4. Leroy EM, Gonzalez JP, Baize S. Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa. Clin Microbiol Infect. 2011 Jul;17(7):964-76.Full text  Abstract

5. Formenty P, Hatz C, Le Guenno B, et al. Human infection due to Ebola virus, subtype Côte d'Ivoire: clinical and biologic presentation. J Infect Dis. 1999 Feb;179 Suppl 1:S48-53.Full text  Abstract

6. Roddy P, Howard N, Van Kerkhove MD, et al. Clinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008. PLoS One. 2012 Dec 28;7(12):e52986.Full text  Abstract

7. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet. 2011 Mar 5;377(9768):849-62.Full text  Abstract

8. Barrette RW, Metwally SA, Rowland JM, et al. Discovery of swine as a host for the Reston ebolavirus. Science. 2009 Jul 10;325(5937):204-6.Full text  Abstract

9. Karan LS, Makenov MT, Korneev MG, et al. Bombali virus in Mops condylurus bats, Guinea. Emerg Infect Dis. 2019 Sep;25(9):1774-5.Full text  Abstract

10. Goldstein T, Anthony SJ, Gbakima A, et al. The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses. Nat Microbiol. 2018 Oct;3(10):1084-9.Full text  Abstract

11. Martell HJ, Masterson SG, McGreig JE, et al. Is the Bombali virus pathogenic in humans? Bioinformatics. 2019 Oct 1;35(19):3553-8.Full text  Abstract

12. Swanepoel R, Smit SB, Rollin PE, et al. Studies of reservoir hosts for Marburg virus. Emerg Infect Dis. 2007 Dec;13(12):1847-51.Full text  Abstract

13. McElroy AK, Erickson BR, Flietstra TD, et al. Ebola hemorrhagic fever: novel biomarker correlates of clinical outcome. J Infect Dis. 2014 Aug 15;210(4):558-66.Full text  Abstract

14. Mahanty S, Bray M. Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect Dis. 2004 Aug;4(8):487-98.Full text  Abstract

15. Yan T, Mu J, Qin E, et al. Clinical characteristics of 154 patients suspected of having Ebola disease in the Ebola holding centre of Jui government hospital in Sierra Leone during the 2014 Ebola outbreak. Eur J Microbiol Infect Dis. 2015 Oct;34(10):2089-95. Abstract

16. Kortepeter MG, Bausch DG, Bray M. Basic clinical and laboratory features of filoviral hemorrhagic fever. J Infect Dis. 2011 Nov;204 Suppl 3:S810-6.Full text  Abstract

17. Bwaka MA, Bonnet MJ, Calain P, et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis. 1999 Feb;179 Suppl 1:S1-7.Full text  Abstract

18. WHO Ebola Response Team. Ebola virus disease in West Africa: the first 9 months of the epidemic and forward projections. N Engl J Med. 2014 Oct 16;371(16):1481-95.Full text  Abstract

19. Dallatomasinas S, Crestani R, Squire JS, et al. Ebola outbreak in rural West Africa: epidemiology, clinical features and outcomes. Trop Med Int Health. 2015 Apr;20(4):448-54. Abstract

20. Bah EI, Lamah MC, Fletcher T, et al. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med. 2015 Jan 1;372(1):40-7.Full text  Abstract

21. Chertow DS, Kleine C, Edwards JK, et al. Ebola virus disease in West Africa - clinical manifestations and management. N Engl J Med. 2014 Nov 27;371(22):2054-7.Full text  Abstract

22. Schieffelin JS, Shaffer JG, Goba A, et al; KGH Lassa Fever Program; Viral Hemorrhagic Fever Consortium; WHO Clinical Response Team. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med. 2014 Nov 27;371(22):2092-100.Full text  Abstract

23. Nkoghe D, Leroy EM, Toung-Mve M, et al. Cutaneous manifestations of filovirus infections. Int J Dermatol. 2012 Sep;51(9):1037-43. Abstract

24. Report of an International Commission. Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ. 1978;56(2):271-93.Full text  Abstract

25. Peterson AT, Bauer JT, Mills JN. Ecologic and geographic distribution of filovirus disease. Emerg Infect Dis. 2004 Jan;10(1):40-7.Full text  Abstract

26. Centers for Disease Control and Prevention. CDC laboratories produce first genomic sequence of Liberian Ebola. August 2015 [internet publication].Full text

27. Ansumana R, Jacobsen KH, Idris M, et al. Ebola in Freetown area, Sierra Leone - a case study of 581 patients. N Engl J Med. 2015 Feb 5;372(6):587-8.Full text  Abstract

28. New York Times. How many Ebola patients have been treated outside of Africa? January 2015 [internet publication].Full text

29. World Health Organization. Disease outbreak news. Ebola disease caused by Sudan ebolavirus - Uganda. November 2022 [internet publication].Full text

30. World Health Organization. Disease outbreak news: Ebola virus disease - Democratic Republic of the Congo. Aug 2022 [internet publication].Full text

31. World Health Organization. Ebola virus disease - Democratic Republic of the Congo. Jul 2022 [internet publication].Full text

32. World Health Organization. Disease outbreak news. Ebola virus disease – Democratic Republic of the Congo. Dec 2021 [internet publication].Full text

33. World Health Organization. Disease outbreak news. Ebola virus disease – Guinea. Jun 2021 [internet publication].Full text

34. World Health Organization. Disease Outbreak News. Ebola - Democratic Republic of the Congo. May 2021 [internet publication].Full text

35. World Health Organization. Disease outbreak news: Ebola virus disease - Democratic Republic of the Congo. Nov 2020 [internet publication].Full text

36. World Health Organization. Ebola health update: north Kivu/Ituri, DRC, 2018-2020. Jul 2020 [internet publication].Full text

37. World Health Organization. WHO recommended criteria for declaring the end of the Ebola virus disease. Mar 2020 [internet publication].Full text

38. Peters CJ, LeDuc JW. An introduction to Ebola: the virus and the disease. J Infect Dis. 1999 Feb;179 Suppl 1:ix-xvi.Full text  Abstract

39. Swanepoel R, Leman PA, Burt FJ, et al. Experimental inoculation of plants and animals with Ebola virus. Emerg Infect Dis. Oct-Dec 1996;2(4):321-5.Full text  Abstract

40. Reiter P, Turell M, Coleman R, et al. Field investigations of an outbreak of Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: arthropod studies. J Infect Dis. 1999 Feb;179 Suppl 1:S148-54.Full text  Abstract

41. Pigott DM, Golding N, Mylne A, et al. Mapping the zoonotic niche of Ebola virus disease in Africa. Elife. 2014 Sep 8;3:e04395.Full text  Abstract

42. Dowell SF, Mukunu R, Ksiazek TG, et al. Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis. 1999 Feb;179 Suppl 1:S87-91.Full text  Abstract

43. Bausch DG, Towner JS, Dowell SF, et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis. 2007 Nov 15;196 Suppl 2:S142-7.Full text  Abstract

44. Osterholm MT, Moore KA, Kelley NS, et al. Transmission of Ebola viruses: what we know and what we do not know. MBio. 2015 Feb 19;6(2):e00137.Full text  Abstract

45. Kreuels B, Wichmann D, Emmerich P, et al. A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med. 2014 Dec 18;371(25):2394-401.Full text  Abstract

46. World Health Organization. Sierra Leone: a traditional healer and a funeral. 2014 [internet publication].Full text

47. Lau MS, Dalziel BD, Funk S, et al. Spatial and temporal dynamics of superspreading events in the 2014-2015 West Africa Ebola epidemic. Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):2337-42.Full text  Abstract

48. Emond RT, Evans B, Bowen ET, et al. A case of Ebola virus infection. Br Med J. 11977 Aug 27;2(6086):541-4.Full text  Abstract

49. Rowe AK, Bertolli J, Khan AS, et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis. 1999 Feb;179 Suppl 1:S28-35. Abstract

50. World Health Organization. Clinical care for survivors of Ebola virus disease: interim guidance. April 2016 [internet publication].Full text

51. Rogstad KE, Tunbridge A. Ebola virus as sexually transmitted infection. Curr Opin Infect Dis. 2015 Feb;28(1):83-5. Abstract

52. Sonnenberg P, Field P. Sexual and mother-to-child transmission of Ebola virus in the post-convalescent period. Clin Infect Dis. 2015 Mar 15;60(6):974-5. Abstract

53. Mate SE, Kugelman JR, Nyenswah TG, et al. Molecular evidence of sexual transmission of Ebola virus. N Engl J Med. 2015 Dec 17;373(25):2448-54.Full text  Abstract

54. Crozier I. Ebola virus RNA in the semen of male survivors of Ebola virus disease: the uncertain gravitas of a privileged persistence. J Infect Dis. 2016 Nov 15;214(10):1467-9.Full text  Abstract

55. Thorson A, Formenty P, Lofthouse C, et al. Systematic review of the literature on viral persistence and sexual transmission from recovered Ebola survivors: evidence and recommendations. BMJ Open. 2016 Jan 7;6(1):e008859.Full text  Abstract

56. Rodriguez LL, De Roo A, Guimard Y, et al. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 1999 Feb;179 Suppl 1:S170-6.Full text  Abstract

57. Centers for Disearse Control and Prevention. Ebola (Ebola virus disease): transmission. November 2019 [internet publication].Full text

58. Judson S, Prescott J, Munster V. Understanding Ebola virus transmission. Viruses. 2015 Feb 3;7(2):511-21.Full text  Abstract

59. Beeching NJ, Fletcher TE, Hill DR, et al. Travellers and viral haemorrhagic fevers: what are the risks? Int J Antimicrob Agents. 2010 Nov;36 Suppl 1:S26-35.Full text  Abstract

60. Carroll M, Matthews DA, Hiscox JA, et al. Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa. Nature. 2015 Aug 6;524(7563):97-101.Full text  Abstract

61. Gire SK, Goba A, Andersen KG, et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science. 2014 Sep 12;345(6202):1369-72.Full text  Abstract

62. Sharma N, Cappell MS. Gastrointestinal and hepatic manifestations of Ebola virus infection. Dig Dis Sci. 2015 Sep;60(9):2590-603. Abstract

63. Ramanan P, Shabman RS, Brown CS, et al. Filoviral immune evasion mechanisms. Viruses. 2011 Sep;3(9):1634-49.Full text  Abstract

64. Ramanan P, Edwards MR, Shabman RS, et al. Structural basis for Marburg virus VP35-mediated immune evasion mechanisms. Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20661-6.Full text  Abstract

65. Ansari AA. Clinical features and pathobiology of Ebolavirus infection. J Autoimmun. 2014 Dec;55:1-9. Abstract

66. Martines RB, Ng DL, Greer PW, et al. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses. J Pathol. 2015 Jan;235(2):153-74. Abstract

67. Falasca L, Agrati C, Petrosillo N, et al. Molecular mechanisms of Ebola virus pathogenesis: focus on cell death. Cell Death Differ. 2015 Aug;22(8):1250-9.Full text  Abstract

68. Fletcher T, Fowler RA, Beeching NJ. Understanding organ dysfunction in Ebola virus disease. Intensive Care Med. 2014 Dec;40(12):1936-9. Abstract

69. Sanchez A, Lukwiya M, Bausch D, et al. Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol. 2004 Oct;78(19):10370-7.Full text  Abstract

70. Rougeron V, Feldmann H, Grard G, et al. Ebola and Marburg haemorrhagic fever. J Clin Virol. 2015 Mar;64:111-9. Abstract

71. Zapata JC, Cox D, Salvato MS. The role of platelets in the pathogenesis of viral hemorrhagic fevers. PLoS Negl Trop Dis. 2014 Jun 12;8(6):e2858.Full text  Abstract

72. Leroy EM, Baize S, Volchkov VE, et al. Human asymptomatic Ebola infection and strong inflammatory response. Lancet. 2000 Jun 24;355(9222):2210-5.Full text  Abstract

73. Ruibal P, Oestereich L, Lüdtke A, et al. Unique human immune signature of Ebola virus disease in Guinea. Nature. 2016 May 5;533(7601):100-4.Full text  Abstract

74. WHO Ebola Response Team. Ebola virus disease among children in West Africa. N Engl J Med. 2015 Mar 26;372(13):1274-7.Full text  Abstract

75. Nielsen CF, Kidd S, Sillah AR, et al. Improving burial practices and cemetery management during an Ebola virus disease epidemic - Sierra Leone, 2014. MMWR Morb Mortal Wkly Rep. 2015 Jan 16;64(1):20-7.Full text  Abstract

76. Georges-Courbot MC, Sanchez A, Lu CY, et al. Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon. Emerg Infect Dis. Jan-Mar 1997;3(1):59-62.Full text  Abstract

77. Strauss S. Ebola research fueled by bioterrorism threat. CMAJ. 2014 Nov 4;186(16):1206.Full text  Abstract

78. Centers for Disease Control and Prevention. Ebola (Ebola virus disease): prevention and vaccine. November 2019 [internet publication].Full text

79. Centers for Disease Control and Prevention. Guidance on personal protective equipment to be used by healthcare workers during management of patients with confirmed Ebola or persons under investigation for Ebola who are clinically unstable or have bleeding, vomiting, or diarrhea in US hospitals, including procedures for donning and doffing PPE. August 2018 [internet publication].Full text

80. Jacobs M, Aarons E, Bhagani S, et al. Post-exposure prophylaxis against Ebola virus disease with experimental antiviral agents: a case-series of health-care workers. Lancet Infect Dis. 2015 Nov;15(11):1300-4.Full text  Abstract

81. WHO: Ebola virus disease: vaccines

82. Centers for Disease Control and Prevention. Use of ebola vaccine: expansion ofrecommendations of the Advisory Committee on Immunization Practices to include twoadditional populations - United States, 2021. Feb 2022 [internet publication].Full text

83. Centers for Disease Control and Prevention. Ebola Vaccine: Information about ERVEBO®. Mar 2022 [internet publication].Full text

84. World Health Organization. Guidelines for the management of pregnant and breastfeeding women in the context of Ebola virus disease. 2020 [internet publication].Full text

85. Conteh MA, Goldstein ST, Wurie HR, et al. Clinical surveillance and evaluation of suspected Ebola cases in a vaccine trial during an Ebola epidemic: the Sierra Leone trial to introduce a vaccine against Ebola. J Infect Dis. 2018 May 18;217(suppl_1):S33-S39.Full text  Abstract

86. Henao-Restrepo AM, Camacho A, Longini IM, et al. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet. 2017 Feb 4;389(10068):505-18.Full text  Abstract

87. World Health Organization. Second Ebola vaccine to complement “ring vaccination” given green light in DRC. September 2019 [internet publication].Full text

88. Kennedy SB, Bolay F, Kieh M, et al. Phase 2 placebo-controlled trial of two vaccines to prevent Ebola in Liberia. N Engl J Med. 2017 Oct 12;377(15):1438-47.Full text  Abstract

89. Fletcher TE, Brooks TJ, Beeching NJ. Ebola and other viral haemorrhagic fevers. BMJ. 2014 Aug 11;349:g5079.Full text  Abstract

90. Centers for Disease Control and Prevention. Case definition for Ebola virus disease (EVD). November 2014 [internet publication].Full text

91. Mendelson M, Han PV, Vincent P, et al. Regional variation in travel-related illness acquired in Africa, March 1997-May 2011. Emerg Infect Dis. 2014 Apr;20(4):532-41.Full text  Abstract

92. Hunt L, Gupta-Wright A, Simms V, et al. Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study. Lancet Infect Dis. 2015 Nov;15(11):1292-9. Abstract

93. World Health Organization. Case definition recommendations for Ebola or Marburg virus diseases. July 2019 [internet publication].Full text

94. Centers for Disease Control and Prevention. Ebola virus disease (EVD): fact sheet. Oct 2018 [internet publication].Full text

95. Rojek AM, Salam A, Ragotte RJ, et al. A systematic review and meta-analysis of patient data from the West Africa (2013-16) Ebola virus disease epidemic. Clin Microbiol Infect. 2019 Nov;25(11):1307-14.Full text  Abstract

96. Glynn JR. Age-specific incidence of Ebola virus disease. Lancet. 2015 Aug 1;386(9992):432.Full text  Abstract

97. Mupere E, Kaducu OF, Yoti Z. Ebola haemorrhagic fever among hospitalised children and adolescents in northern Uganda: epidemiologic and clinical observations. Afr Health Sci. 2001 Dec;1(2):60-5.Full text  Abstract

98. Peacock G, Uyeki TM, Rasmussen SA. Ebola virus disease and children: what pediatric health care professionals need to know. JAMA Pediatr. 2014 Dec;168(12):1087-8.Full text  Abstract

99. Fitzgerald F, Naveed A, Wing K, et al. Ebola virus disease in children, Sierra Leone, 2014-2015. Emerg Infect Dis. 2016 Oct;22(10):1769-77.Full text  Abstract

100. Shah T, Greig J, van der Plas LM, et al. Inpatient signs and symptoms and factors associated with death in children aged 5 years and younger admitted to two Ebola management centres in Sierra Leone, 2014: a retrospective cohort study. Lancet Glob Health. 2016 Jul;4(7):e495-501.Full text  Abstract

101. Dananché C, Bénet T, Vanhems P. Ebola: fever definitions might delay detection in non-epidemic areas. Lancet. 2014 Dec;168(12):1087-8.Full text  Abstract

102. Lado M, Howlett P. Ebola virus disease in children: towards a better clinical picture and improved management. Lancet Glob Health. 2016 Jul;4(7):e436-7.Full text  Abstract

103. Lópaz MA, Amela C, Ordobas M, et al; Working group of Ebola outbreak investigation team of Madrid. First secondary case of Ebola outside Africa: epidemiological characteristics and contact monitoring, Spain, September to November 2014. Euro Surveill. 2015 Jan 8;20(1):21003.Full text

104. Lyon GM, Mehta AK, Varkey JB, et al; Emory Serious Communicable Diseases Unit. Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med. 2014 Dec 18;371(25):2402-9.Full text  Abstract

105. World Health Organization. Exit screening at airports, ports and land crossings: interim guidance for Ebola virus disease. November 2014 [internet publication].Full text

106. Petrosillo N, Nicastri E, Lanini S, et al. Ebola virus disease complicated with viral interstitial pneumonia: a case report. BMC Infect Dis. 2015 Oct 16;15:432.Full text  Abstract

107. World Health Organization. Laboratory diagnosis of Ebola virus disease: interim guidance. September 2014 [internet publication].Full text

108. Cherpillod P, Schibler M, Vieille G, et al. Ebola virus disease diagnosis by real-time RT-PCR: a comparative study of 11 different procedures. J Clin Virol. 2016 Apr;77:9-14.Full text  Abstract

109. Towner JS, Rollin PE, Bausch DG, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol. 2004 Apr;78(8):4330-41.Full text  Abstract

110. Boggild AK, Esposito DH, Kozarsky PE, et al. Differential diagnosis of illness in travelers arriving from Sierra Leone, Liberia, or Guinea: a cross-sectional study from the GeoSentinel Surveillance Network. Ann Intern Med. 2015 Jun 2;162(11):757-64. Abstract

111. McElroy AK, Erickson BR, Flietstra TD, et al. Biomarker correlates of survival in pediatric patients with ebola virus disease. Emerg Infect Dis. 2014 Oct;20(10):1683-90.Full text  Abstract

112. Fowler RA, Fletcher T, Fischer WA 2nd, et al. Caring for critically ill patients with Ebola virus disease. Perspectives from West Africa. Am J Respir Crit Care Med. 2014 Oct 1;190(7):733-7.Full text  Abstract

113. Rollin PE, Bausch DG, Sanchez A. Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus. J Infect Dis. 2007 Nov 15;196 Suppl 2:S364-71.Full text  Abstract

114. Dickson SJ, Clay KA, Adam M, et al. Enhanced case management can be delivered for patients with EVD in Africa: experience from a UK military Ebola treatment centre in Sierra Leone. J Infect. 2018 Apr;76(4):383-92.Full text  Abstract

115. Lamb L, Robson J, Ardley C, et al. Bacterial co-infection is rare in patients with Ebola virus disease in a military Ebola virus disease treatment unit in Sierra Leone. J Infect. 2015 Sep;71(3):406-7. Abstract

116. Auffermann WF, Kraft CS, Vanairsdale S, et al. Radiographic imaging for patients with contagious infectious diseases: how to acquire chest radiographs of patients infected with the Ebola virus. AJR Am J Roentgenol. 2015 Jan;204(1):44-8. Abstract

117. Butler D. Ebola experts seek to expand testing. Nature. 2014 Dec 11;516(7530):154-5.Full text  Abstract

118. Burd EM. Ebola virus: a clear and present danger. J Clin Microbiol. 2015 Jan;53(1):4-8.Full text  Abstract

119. Hoenen T, Groseth A, Rosenke K, et al. Nanopore sequencing as a rapidly deployable ebola outbreak tool. Emerg Infect Dis. 2016 Feb;22(2):331-4.Full text  Abstract

120. Tsang MK, Ye W, Wang G, et al. Ultrasensitive detection of ebola virus oligonucleotide based on upconversion nanoprobe/nanoporous membrane system. ACS Nano. 2016 Jan 26;10(1):598-605. Abstract

121. Quick J, Loman NJ, Duraffour S, et al. Real-time, portable genome sequencing for Ebola surveillance. Nature. 2016 Feb 11;530(7589):228-32Full text  Abstract

122. Semper AE, Broadhurst MJ, Richards J, et al. Performance of the GeneXpert Ebola assay for diagnosis of Ebola virus disease in Sierra Leone: a field evaluation study. PLoS Med. 2016 Mar 29;13(3):e1001980.Full text  Abstract

123. Moshirfar M, Fenzl CR, Li Z. What we know about ocular manifestations of Ebola. Clin Ophthalmol. 2014 Nov 21;8:2355-7.Full text  Abstract

124. Lado M, Walker N, Baker P, et al. Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study. Lancet Infect Dis. 2015 Sep;15(9):1024-33. Abstract

125. Food and Drug Administration. FDA authorizes emergency use of first Ebola fingerstick test with portable reader. November 2018 [internet publication].Full text

126. Food and Drug Administration. FDA allows marketing of first rapid diagnostic test for detecting Ebola virus antigens. October 2019 [internet publication].Full text

127. Hensley LE, Wahl-Jensen V, McCormick JB, et al. Viral hemorrhagic fevers. In: Cohen J, Powderly W, Opal S, eds. Infectious Diseases. 3rd ed. Maryland Heights, MO: Mosby; 2010:1231-7.

128. Hartskeerl RA, Collares-Pereira M, Ellis WA. Emergence, control and re-emerging leptospirosis: dynamics of infection in the changing world. Clin Microbiol Infect. 2011 Apr;17(4):494-501.Full text  Abstract

129. Wolf T, Kann G, Becker S, et al. Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care. Lancet. 2015 Apr 11;385(9976):1428-35.Full text  Abstract

130. Parra JM, Salmerón OJ, Velasco M. The first case of Ebola virus disease acquired outside Africa. N Engl J Med. 2014 Dec 18;371(25):2439-40.Full text  Abstract

131. Uyeki TM, Mehta AK, Davey RT Jr, et al. Clinical management of Ebola virus disease in the United States and Europe. N Engl J Med. 2016 Feb 18;374(7):636-46.Full text  Abstract

132. Zacharowski K, Brodt HR, Wolf T. Medical treatment of an Ebola-infected doctor -ethics over costs? Lancet. 2015 Feb 21;385(9969):685.Full text  Abstract

133. Solano T, Gilbert GL, Kerridge IH, et al. Ethical considerations in the management of Ebola virus disease. Med J Aust. 2015 Aug 17;203(4):193-5e.1. Abstract

134. Jacobs M, Beadsworth M, Schmid M, et al. Provision of care for Ebola. Lancet. 2014 Dec 13;384(9960):2105-6.Full text  Abstract

135. Decker BK, Sevransky JE, Barrett K, et al. Preparing for critical care services to patients with ebola. Ann Intern Med. 2014 Dec 2;161(11):831-2.Full text  Abstract

136. Canadian Critical Care Society; Canadian Association of Emergency Physicians; Association of Medical Microbiology and Infectious Diseases of Canada. Ebola clinical care guidelines: a guide for clinicians in Canada. October 2014 [internet publication].Full text

137. Rees PS, Lamb LE, Nicholson-Roberts TC, et al. Safety and feasibility of a strategy of early central venous catheter insertion in a deployed UK military Ebola virus disease treatment unit. Intensive Care Med. 22015 May;41(5):735-43. Abstract

138. World Health Organization. Optimized supportive care for Ebola virus disease. July 2019 [internet publication].Full text

139. Lamontagne F, Fowler RA, Adhikari NK, et al. Evidence-based guidelines for supportive care of patients with Ebola virus disease. Lancet. 2018 Feb 17;391(10121):700-8.Full text  Abstract

140. Perner A, Fowler R, Bellomo R, et al. Ebola care and research protocols. Intensive Care Med. 2015 Jan;41(1):111-4. Abstract

141. Roberts I, Perner A. Ebola virus disease: clinical care and patient-centred research. Lancet. 2014 Dec 6;384(9959):2001-2.Full text  Abstract

142. Clay KA, Johnston AM, Moore A, et al. Targeted electrolyte replacement in patients with Ebola virus disease. Clin Infect Dis. 2015 Sep 15;61(6):1030-1. Abstract

143. World Health Organization. Manual for the care and management of patients in Ebola care units/community care centres: interim emergency guidance. January 2015 [internet publication].Full text

144. Kendall RE, Gosser RA, Schulz LT, et al. Anti-diarrheal medication use in the treatment of Ebola virus-induced diarrhea. Travel Med Infect Dis. 2015 Mar-Apr;13(2):205-6. Abstract

145. Chertow DS, Uyeki TM, DuPont HL. Loperamide therapy for voluminous diarrhea in Ebola virus disease. J Infect Dis. 2015 Apr 1;211(7):1036-7.Full text  Abstract

146. World Health Organization. Clinical management of patients with viral haemorrhagic fever: a pocket guide for the front-line health worker. February 2016 [internet publication].Full text

147. Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021 Nov 1;49(11): e1063-e1143.Full text  Abstract

148. Wada H, Thachil J, Di Nisio M, et al. Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost. 2013 Feb 4;11(4):761-7.Full text  Abstract

149. Warren T, Jordan R, Lo M, et al. Nucleotide prodrug GS-5734 is a broad-spectrum Filovirus inhibitor that provides complete therapeutic protection against the development of Ebola Virus Disease (EVD) in infected non-human primates. Late breaker abstract 2. Presented at IDWeek. San Diego, 2015.Full text

150. Connor MJ Jr, Kraft C, Mehta AK, et al. Successful delivery of RRT in Ebola virus disease. J Am Soc Nephrol. 2015 Jan;26(1):31-7. Abstract

151. World Health Organization. Interim guidance: potential Ebola therapies and vaccines. November 2014 [internet publication].Full text

152. Kreil TR. Treatment of Ebola virus infection with antibodies from reconvalescent donors. Emerg Infect Dis. 2015 Mar;21(3):521-3.Full text  Abstract

153. Gutfraind A, Myers LA. Evaluating large-scale blood transfusion therapy for the current Ebola epidemic in Liberia. J Infect Dis. 22015 Apr 15;211(8):1262-7.Full text  Abstract

154. van Griensven J, Edwards T, de Lamballerie X, et al. Evaluation of convalescent plasma for Ebola virus disease in Guinea. N Engl J Med. 2016 Jan 7;374(1):33-42.Full text  Abstract

155. van Griensven J, De Weiggheleire A, Delamou A, et al. The use of Ebola convalescent plasma to treat Ebola virus disease in resource-constrained settings: a perspective from the field. Clin Infect Dis. 2016 Jan 1;62(1):69-74.Full text  Abstract

156. World Health Organization. Therapeutics for Ebola virus disease - Democratic Republic of the Congo. Aug 2022 [internet publication].Full text

157. Mulangu S, Dodd LE, Davey RT Jr, et al. A randomized, controlled trial of Ebola virus disease therapeutics. N Engl J Med. 2019 Dec 12;381(24):2293-303.Full text  Abstract

158. Foeller ME, Carvalho Ribeiro do Valle C, Foeller TM, et al. Pregnancy and breastfeeding in the context of Ebola: a systematic review. Lancet Infect Dis. 2020 Jul;20(7):e149-58.Full text  Abstract

159. Mupapa K, Mukundu W, Bwaka MA, et al. Ebola hemorrhagic fever and pregnancy. J Infect Dis. 1999 Feb;179 Suppl 1:S11-2.Full text  Abstract

160. Baggi FM, Taybi A, Kurth A, et al. Management of pregnant women infected with Ebola virus in a treatment centre in Guinea, June 2014. Euro Surveill. 2014 Dec 11;19(49):20983.Full text  Abstract

161. Jamieson DJ, Uyeki TM, Callaghan WM, et al. What obstetrician-gynecologists should know about Ebola: a perspective from the Centers for Disease Control and Prevention. Obstet Gynecol. 2014 Nov;124(5):1005-10. Abstract

162. Association of Women's Health, Obstetric and Neonatal Nurses. Ebola: caring for pregnant and postpartum women and newborns in the United States: AWHONN practice brief number 3. J Obstet Gynecol Neonat Nurs. 2015 Jan-Feb;44(1):164-5Full text  Abstract

163. Kitching A, Walsh A, Morgan D. Ebola in pregnancy: risk and clinical outcomes. BJOG. 2015 Feb;122(3):287. Abstract

164. Olupot-Olupot P. Ebola in children: epidemiology, clinical features, diagnosis and outcomes. Pediatr Infect Dis J. 2015 Mar;34(3):314-6. Abstract

165. Herberg JA, Emonts M, Jacobs M, et al. UK preparedness for children with Ebola infection. Arch Dis Child. 2015 May;100(5):421-3. Abstract

166. Eriksson CO, Uyeki TM, Christian MD, et al. Care of the child with Ebola virus disease. Pediatr Crit Care Med. 2015 Feb;16(2):97-103. Abstract

167. Bishop BM. Potential and emerging treatment options for Ebola virus disease. Ann Pharmacother. 2015 Feb;49(2):196-206. Abstract

168. Goodman JL. Studying "secret serums": toward safe, effective Ebola treatments. N Engl J Med. 2014 Sep 18;371(12):1086-9.Full text  Abstract

169. Zhang Y, Li D, Jin X, et al. Fighting Ebola with ZMapp: spotlight on plant-made antibody. Sci China Life Sci. 2014 Oct;57(10):987-8. Abstract

170. Qiu X, Wong G, Audet J, et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature. 2014 Oct 2;514(7520):47-53.Full text  Abstract

171. Furuta Y, Takahashi K, Shiraki K, et al. T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections. Antiviral Res. 2009 Jun;82(3):95-102. Abstract

172. Sissoko D, Laouenan C, Folkesson E, et al. Experimental treatment with favipiravir for Ebola virus disease (the JIKI trial): a historically controlled, single-arm proof-of-concept trial in Guinea. PLoS Med. 2016 Mar 1;13(3):e1001967.Full text  Abstract

173. WHO Ebola Response Team. Ebola virus disease among male and female persons in West Africa. N Engl J Med. 2016 Jan 7;374(1):96-8.Full text  Abstract

174. Sadek RF, Khan AS, Stevens G, et al. Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival. J Infect Dis. 1999 Feb;179 Suppl 1:S24-7.Full text  Abstract

175. Lauck M, Bailey AL, Andersen KG, et al. GB virus C co-infections in West African Ebola patients. J Virol. 2015 Feb;89(4):2425-9.Full text  Abstract

176. Deen GF, Broutet N, Xu W, et al. Ebola RNA persistence in semen of Ebola virus disease survivors - final report. N Engl J Med. 2017 Oct 12;377(15):1428-37.Full text  Abstract

177. Soka MJ, Choi MJ, Baller A, et al. Prevention of sexual transmission of Ebola in Liberia through a national semen testing and counselling programme for survivors: an analysis of Ebola virus RNA results and behavioural data. Lancet Glob Health. 2016 Oct;4(10):e736-43.Full text  Abstract

178. Etard JF, Sow MS, Leroy S, et al; Postebogui Study Group. Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study. Lancet Infect Dis. 2017 May;17(5):545-52.Full text  Abstract

179. PREVAIL III Study Group, Sneller MC, Reilly C, et al. A longitudinal study of Ebola sequelae in Liberia. N Engl J Med. 2019 Mar 7;380(10):924-34.Full text  Abstract

180. Chughtai AA, Barnes M, Macintyre CR. Persistence of Ebola virus in various body fluids during convalescence: evidence and implications for disease transmission and control. Epidemiol Infect. 2016 Jun;144(8):1652-60.Full text  Abstract

181. Mattia JG, Vandy MJ, Chang JC, et al. Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study. Lancet Infect Dis. 2016 Mar;16(3):331-8. Abstract

182. Scott JT, Sesay FR, Massaquoi TA, et al. Post-Ebola syndrome, Sierra Leone. Emerg Infect Dis. 2016 Apr;22(4):641-6.Full text  Abstract

183. Tiffany A, Vetter P, Mattia J, et al. Ebola virus disease complications as experienced by survivors in Sierra Leone. Clin Infect Dis. 2016 Jun 1;62(11):1360-6.Full text  Abstract

184. PREVAIL III Study Group, Sneller MC, Reilly C, et al. A longitudinal study of Ebola sequelae in Liberia. N Engl J Med. 2019 Mar 7;380(10):924-34.Full text  Abstract

185. Shantha JG, Yeh S, Nguyen QD. Ebola virus disease and the eye. Curr Opin Ophthalmol. 2016 Nov;27(6):538-44. Abstract

186. Shantha JG, Crozier I, Hayek BR, et al. Ophthalmic manifestations and causes of vision impairment in Ebola virus disease survivors in Monrovia, Liberia. Ophthalmology. 2017 Feb;124(2):170-7. Abstract

187. Varkey JB, Shanth JG, Crozier I, et al. Persistence of Ebola virus in ocular fluid during convalescence. N Engl J Med. 2015 Jun 18;372(25):2423-7. Abstract

188. Chancellor JR, Padmanabhan SP, Greenough TC, et al. Uveitis and systemic inflammatory markers in convalescent phase of Ebola virus disease. Emerg Infect Dis. 2016 Feb;22(2):295-7.Full text  Abstract

189. Steptoe PJ, Scott JT, Baxter JM, et al. Novel retinal lesion in Ebola survivors, Sierra Leone, 2016. Emerg Infect Dis. 2017 Jul;23(7):1102-9.Full text  Abstract

190. Thom R, Tipton T, Strecker T, et al. Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study. Lancet Infect Dis. 2020 Oct 13;S1473-3099(20)30736-2.Full text  Abstract

191. Jacobs M, Rodger A, Bell DJ, et al. Late Ebola virus relapse causing meningoencephalitis: a case report. Lancet. 2016 Jul 30;388(10043):498-503.Full text  Abstract

192. Howlett P, Brown C, Helderman T, et al. Ebola virus disease complicated by late-onset encephalitis and polyarthritis, Sierra Leone. Emerg Infect Dis. 2016 Jan;22(1):150-2.Full text  Abstract

193. Dokubo EK, Wendland A, Mate SE, et al. Persistence of Ebola virus after the end of widespread transmission in Liberia: an outbreak report. Lancet Infect Dis. 2018 Sep;18(9):1015-24.Full text  Abstract

194. Locsin RC, Barnard A, Matua AG, et al. Surviving Ebola: understanding experience through artistic expression. Int Nurs Rev. 2003 Sep;50(3):156-66. Abstract

195. De Roo A, Ado B, Rose B, et al. Survey among survivors of the 1995 Ebola epidemic in Kikwit, Democratic Republic of Congo: their feelings and experiences. Trop Med Int Health. 1998 Nov;3(11):883-5.Full text  Abstract

196. Cénat JM, Felix N, Blais-Rochette C, et al. Prevalence of mental health problems in populations affected by the Ebola virus disease: a systematic review and meta-analysis. Psychiatry Res. 2020 Apr 29;289:113033.Full text  Abstract

197. James PB, Wardle J, Steel A, et al. Post-Ebola psychosocial experiences and coping mechanisms among Ebola survivors: a systematic review. Trop Med Int Health. 2019 Jun;24(6):671-91.Full text  Abstract

198. World Health Organization. Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease for transfusion, as an empirical treatment during outbreaks. September 2014 [internet publication].Full text

199. Wong KK, Davey RT Jr, Hewlett AL, et al. Use of post-exposure prophylaxis after occupational exposure to Zaire ebolavirus. Clin Infect Dis. 2016 Aug 1;63(3):376-9. Abstract

200. Fischer WA Nd, Vetter P, Bausch DG, et al. Ebola virus disease: an update on post-exposure prophylaxis. Lancet Infect Dis. 2017 Nov 15. pii: S1473-3099(17)30677-1.Full text  Abstract

201. Savini H, Ficko C, Simon F. Post-exposure prophylaxis in Ebola virus disease: don't forget the psychological factors. Lancet Infect Dis. 2018 Apr;18(4):378.Full text  Abstract

Use of this content is subject to our disclaimer